# Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

> **NCT01682499** · PHASE1 · COMPLETED · sponsor: **Beth Israel Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Paclitaxel-induced Neuropathy

## Interventions

- **DRUG:** calcium gluconate and magnesium sulfate

## Key facts

- **NCT ID:** NCT01682499
- **Lead sponsor:** Beth Israel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01682499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01682499, "Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01682499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*